Literature DB >> 12919427

The RHCE allele ceRT: D epitope 6 expression does not require D-specific amino acids.

Franz F Wagner1, Birgit Ladewig, Willy A Flegel.   

Abstract

BACKGROUND: False-positive D typing in patients may lead to anti-D immunization caused by D+ transfusions or by omission of anti-D prophylaxis. Known causes of such errors are RhCE variants carrying RhD-specific amino acids and cold agglutinin activity of some frequently used monoclonal anti-D. STUDY DESIGN AND METHODS: The molecular basis of eight samples referred because of "false-positive" reactions with some commercial monoclonal anti-D was investigated by PCR and nucleotide sequencing from genomic DNA. PCR with sequence-specific priming was developed to specifically detect the underlying aberrant RHCE allele. The D epitope profile of the allele was determined by serology.
RESULTS: The aberrant reactivity of the samples was caused by the RHCE allele RHCE(R154T) that occurred in a cde haplotype. The phenotype dubbed ceRT expressed the important D epitope 6, which is the target epitope of most monoclonal anti-D used in routine typing. DISCUSSION: The characterization of ceRT demonstrated a previously unknown mechanism of antigen D expression that does not require any D-specific amino acid. At least for some D epitopes, D-like structures may be mimicked by RhCE proteins carrying amino acid substitutions not representative for RhD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919427     DOI: 10.1046/j.1537-2995.2003.00495.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  12 in total

1.  Insights into RHCE Molecular Analysis in Samples with Partial D Variants: the Experience of Western France.

Authors:  Yann Fichou; Cédric Le Maréchal; Virginie Scotet; Déborah Jamet; Claude Férec
Journal:  Transfus Med Hemother       Date:  2015-07-23       Impact factor: 3.747

2.  RHD PCR of D-Negative Blood Donors.

Authors:  Franz F Wagner
Journal:  Transfus Med Hemother       Date:  2013-05-08       Impact factor: 3.747

3.  Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions.

Authors:  Sarah J Waldis; Stacey Uter; Donna Kavitsky; Cynthia Flickinger; Sunitha Vege; David F Friedman; Connie M Westhoff; Stella T Chou
Journal:  Blood Adv       Date:  2021-02-09

4.  Distribution of Rhesus blood group antigens and weak D alleles in the population of Albania.

Authors:  Merita Xhetani; Irena Seferi; Claude Férec; Grigor Zoraqi; Yann Fichou
Journal:  Blood Transfus       Date:  2014-06-12       Impact factor: 3.443

Review 5.  The structure and function of the Rh antigen complex.

Authors:  Connie M Westhoff
Journal:  Semin Hematol       Date:  2007-01       Impact factor: 3.851

6.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

7.  Sequence-Based Typing of Human Blood Groups.

Authors:  Axel Seltsam; Andrea Doescher
Journal:  Transfus Med Hemother       Date:  2009-05-14       Impact factor: 3.747

Review 8.  DNA-based methods in the immunohematology reference laboratory.

Authors:  Marion E Reid; Gregory A Denomme
Journal:  Transfus Apher Sci       Date:  2011-01-22       Impact factor: 1.764

Review 9.  Transfusion Support of Minority Patients: Extended Antigen Donor Typing and Recruitment of Minority Blood Donors.

Authors:  Jenna Khan; Meghan Delaney
Journal:  Transfus Med Hemother       Date:  2018-07-19       Impact factor: 3.747

10.  RhCE protein variants in Southwestern Germany detected by serologic routine testing.

Authors:  Peter Bugert; Erwin A Scharberg; Christof Geisen; Inge von Zabern; Willy A Flegel
Journal:  Transfusion       Date:  2009-05-18       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.